STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABSI
  4. [SCHEDULE 13G/A] Absci Corporation SEC Filing

[SCHEDULE 13G/A] Absci Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ABSI logo
Absci Corp

NASDAQ:ABSI

ABSI Rankings

#4793 Ranked by Market Cap
N/A Ranked by Dividends

ABSI Latest News

Jul 7, 2025
Absci Appoints Biopharma Leader Mary Szela to Board of Directors
May 20, 2025
Absci to Participate in Upcoming Investor Conferences
May 13, 2025
Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
May 13, 2025
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
Apr 14, 2025
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

ABSI Latest SEC Filings

Jul 9, 2025
[Form 4] Absci Corporation Insider Trading Activity
Jul 9, 2025
[Form 3] Absci Corporation Initial Statement of Beneficial Ownership
Jul 8, 2025
[8-K] Absci Corporation Reports Material Event

ABSI Stock Data

360.99M
113.55M
15.17%
56.65%
16.6%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER